Search

The Czech medicines regulator SÚKL has granted consent to begin phase II B clinical evaluation of DUOFAG®. This follows completed phase I, which confirmed the product’s safety, and ongoing phase II A examining efficacy in patients with comp

Save the date: JAFRAL Phage Summit 2027, 20–22 May at Grand Hotel Union in Ljubljana, Slovenia. For the second edition, organizers plan more compassionate-use cases and patient stories, more poster presentations, and travel grants for early

One Health, One Solution brings together scientists, early-career researchers, clinicians, regulatory experts and industry professionals to discuss bacteriophage therapy against antimicrobial resistance. Via www.bits-pilani.ac.in. BITS Pil

Registration is now open for Day 1 of the 3rd PhageAfrica Symposium (APF 2026). Join us for discussions on phage biology and applications across animal health, agriculture and food systems. Featured speakers: Dr Hany Anany, Dr Angela Makumi

This review describes clinical laboratory barriers to phage therapy in the United States, including inconsistent susceptibility testing and selection, a lack of phage–antibiotic synergy testing, and limited standard methods for testing phag

The 2026 Phage Therapy 101 course includes a live online speaker Q&A on November 27. The course page says recordings will be sent November 16; an exact Q&A clock time is not stated. Phage Australia

The eighth Bacteriophage Therapy Summit brought industry, academic, policy and investment leaders together in London over three days to discuss turning phage therapies into market-ready products. Via bacteriophage-summit.com. London Bacter

Berkeley Lab speaks with Aeron Tynes Hammack about how physics, biology and nanofabrication connect in his research. The interview traces work at EpiBiome and Locus Biosciences and discusses the Phage Foundry as a shared research resource.

An ANSM letter dated May 28, 2026 authorized HCL to manufacture production intermediates and purified therapeutic phage pharmaceutical raw materials under GMP standards. Its PHAGEinLYON programme began in 2017. Hospices Civils de Lyon — exa

The University of Wrocław team describes KLEOPATRA as a research project exploring phages and phage enzymes alongside antibiotics for Klebsiella pneumoniae. The approach combines phages with enzymes that degrade the bacterial capsule. Unive

At GAMRIC 2026, JAFRAL CEO Frenk Smrekar joined John Rex, Radu Botgros and Gauri Rao for a panel on phage therapy as a narrow-spectrum antimicrobial strategy, from product concept to late-stage clinical development. Frenk Smrekar

EUCAST has established its Phage Susceptibility Testing (PST) Subcommittee to develop standardized methods for testing therapeutic phages. Frédéric Laurent is chair and Annika Classen is scientific secretary. EUCAST

PrecisionPhage lists the two-day Global Phage Therapy Bridge conference at Fairmont Singapore for January 27–28, 2027. Via gptb-register.precisionphage.com. Fairmont Singapore, 80 Bras Basah Road, Singapore gptb-register.precisionphage.com

Phage Pathways’ October speakers span phage therapy, drug development, cell biology, environmental planning and public health. All sessions are virtual on Zoom and open to the community. Via Muryam Gourdet — visible author via Jeremy Barr

NexaBiome has received continued funding from Scotland’s national economic development agency for its bacteriophage technology targeting diabetic foot infections. Bacteriophage.news

IAS–USA hosts a free November 30 webinar on phage biology and translation, susceptibility testing, and AI-assisted phage discovery, with a question-and-answer session. Registration deadline: Monday, November 30, 2026, 8:30 AM (PT). Via ww

The Phage Collection Project was a flagship exhibit at the Royal Society Summer Science Exhibition from July 1–6, 2025. Project lead Franklin and coordinator Esme presented how phages could tackle antibiotic resistance, and the team launche

The NIH CAPT-CEP RFA solicited applications for centers developing preclinical assays, tools and models for phage therapy research and development, and advancing phage clinical research. The NIH notice is expired; its application deadline w

Adelaide University, AusHealth, EB Partnerships Australia (EBRPA) and the SMART Cooperative Research Centre are developing bacteriophage therapy for chronic wound infections in people with epidermolysis bullosa, in the SMART CRC's first col

The Phage Collection Project is a citizen-science initiative run by early career researchers at the University of Southampton. It aims to advance phage therapy research through public education, a biobank of clinical bacterial strains, and